SEARCH

SEARCH BY CITATION

References

  • Agutu W (1997) Short-Course Tuberculosis Chemotherapy in rural Somalia. East African Medical Journal 74, 348352.
  • Baba H, Shinkai A & Izuchi R (1984) Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Bulletin of the International Union against Tuberculosis 59, 2629.
  • Barr R & Menzies R (1994) The effect of war on tuberculosis. Tubercle and Lung Disease 75, 251259.
  • Borgdorff MW, Floyd K & Broekmans JF (2002) Interventions to reduce tuberculosis mortality and transmission in low and middle-income countries. Bulletin of the World Health Organization 80, 217227.
  • Buchanan Smith M & Maxwell S (1994) Linking relief to development: an introduction and overview. IDS Bulletin 25, 4.
  • Burkle FM (1999) Lessons learnt and future expectations of complex emergencies. British Medical Journal 319, 422426.
  • Centers for Disease Control and Prevention (2002) Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. Morbity and Mortality Weekly Reports 51, 214215.
  • DeCock K (1994) Impact of interaction with HIV. In: Tuberculosis back to the future (eds JPorter & KMcAdam), John Wiley & Sons, Chichester, pp. 3549.
  • Dejonghe E, Murray CJL, Chum H, Nyangulu D, Salomao A & Styblo K (1994) Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. International Journal of Health Planning & Management 9, 151181.
  • Dutt A, Moers D & Stead W (1989) Smear and culture-negative pulmonary Tuberculosis: 4-month short course chemotherapy. American Reviews of Respiratory Disease 139, 867870.
  • East African/BMRC study (1981) Controlled Clinical Trial of five Short Course (4 month) Chemotherapy regimens in Pulmonary Tuberculosis. American Reviews of Respiratory Disease 123, 165170.
  • Enarson D & Rouillon A (1994) The epidemiological basis of tuberculosis control. In: Clinical Tuberculosis (ed PDavies), Chapman & Hall, London; pp. 1930.
  • Grzybowski S & Enarson D (1978) The fate of cases of pulmonary tuberculosis under various treatment Programmes. Bulletin of International Union against Tuberculosis and Lung Disease 53, 7075.
  • Hong Kong Chest service/BMRC (1982) Controlled trial of four 3-times-weekly regimens and a daily regimen all given for 6-months for pulmonary tuberculosis, second report: the results up to 24 months. Tubercle 63, 8998.
  • Hong Kong Chest service/TB research centre, Madras/BMRC (1984) A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative- pulmonary tuberculosis. American Reviews of Respiratory Disease 130, 2328.
  • Hong Kong Chest service/BMRC (1987) Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. American Reviews of Respiratory Disease 136, 13391342.
  • Hong Kong Chest service/TB research centre, Madras/BMRC (1989) A Controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum smear negative-pulmonary tuberculosis. American Reviews of Respiratory Disease 139, 871876.
  • Lutfey M, Della-Latta P, Kapur V et al. (1996) Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. American Journal of Respiratory and Critical Care Medicine 153, 837840.
  • Macrae J & Zwi A (1994) Famine, complex emergencies and international policy in Africa: an overview. In: War and Hunger: Rethinking international responses to complex emergencies (eds JMacrae, A Zwi, M Duffield & HSlim), Zed Books, London, pp. 636.
  • March F, Garria X, Rodriguez P et al. (1997) Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clinical Infectious Diseases 25, 10441047.
  • Murray C, Styblo K & Rouillon A (1990) Tuberculosis in developing countries: burden, intervention and cost. Bulletin of International Union against Tuberculosis and Lung Disease 65, 623.
  • Murray C, Styblo K & Rouillon A (1993) Tuberculosis. In: Diseases Control Priorities in Developing Countries (eds DJamison, WMosley, AMeasham & JLBobadilla), Oxford Medical Publications, Oxford, pp. 233259.
  • Perlman DC & Salomon N (1996) Selective malabsorption and the origin of mono-rifampin resistant Mycobacterium tuberculosis. (Correspondence). American Journal of Respiratory and Critical Care Medicine 154, 1213.
  • Perriëns J, St. Louis M, Mukadi et al. YB (1995) Pulmonary tuberculosis in HIV infected patients in Zaire. New England Journal of Medicine 332, 779784.
  • Shimao T (1986) Review of tuberculosis control programmes in the Far East Region of the IUATLD. Bulletin of the International Union against Tuberculosis and Lung Disease 64, 720.
  • Schulzer M, Fitzgerald J, Enarson D & Grzybowski S (1992) An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. Tubercle and Lung Disease 73, 5258.
  • Singapore Tuberculosis Service/BMRC (1981) Clinical trial of 6-month and 4-month regimens of chemo-therapy in the treatment of pulmonary tuberculosis the results up to 30 months. Tubercle 62, 95102.
  • Singapore Tuberculosis Service/BMRC (1986) Long-term Follow-up of a Clinical Trial of 6-month and 4-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. American Reviews of Respiratory Disease 133, 779783.
  • Singapore Tuberculosis Service/BMRC (1988) Five-year follow-up of a Clinical Trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. American Reviews of Respiratory Disease 137, 1471150.
  • Sonnenberg P, Murray J, Glynn J, Shearer S, Kambashi B & Godfrey-Faussett P (2001) HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358, 16871693.
  • TB Research Centre Madras and National TB Institute, Bangalore, (1986) A controlled trial of 3- and 5-month regimens in the treatment of sputum-smear-positive pulmonary tuberculosis. American Reviews of Respiratory Disease 134, 2733.
  • TB Research Centre Madras and National TB Institute, Bangalore, (1990) 5-year result of a 3- and 5-month regimen for the treatment of sputum-positive pulmonary tuberculosis. Tubercle 71, 253258.
  • Van Ham T (1998) Report on interviews with agencies responsible for TB programs in Southern Sudan. 11/97–02/98. New Sudan Council of Churches.
  • Van Herp M (1998) Somalia. Evaluation of the TB programme in Kismayu (MSF Belgium).
  • Tuberculosis Research Centre, Madras, (1983) Study of chemotherapy regimens of 5 and 7 months’ duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary TB in South India. Tubercle 64, 7391.
  • Vynnycky E & Fine PE (1998) The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers. Epidemiology and Infection 121, 309324.
  • WHO (1997) The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis Drug Resistance in the World (WHO/TB/97.229) WHO, Geneva.
  • WHO, UNHCR (1997) Tuberculosis Control in Refugee Situations: An Inter-agency Field Manual (Global Tuberculosis Programme) (WHO/TB/97.221), WHO, Geneva.